Skip to main content
Executive Committee

The Executive Committee serves a dual function, acting as both the elected Board of Trustees and the executive leadership team, ensuring continuity, strategic oversight, and operational delivery.

 

Professor Phil Chowienczyk

President

2026 - 2028

Phil Chowienczyk  is Professor of Cardiovascular Clinical Pharmacology at the School of Cardiovascular Medicine & Sciences, King’s College London. Phil worked in biomedical engineering before studying medicine at Guy’s Hospital Medical School. His research relates to the in vivo assessment of cardiovascular structure and function in humans with the aim of elucidating mechanisms leading to arterial disease and interventions to prevent/treat arterial disease. Phil currently leads a programme on stratified mechanisms in hypertension. He retains an interest in biomedical engineering in relation to non-invasive assessment of cardiovascular function.

 

 

Professor Dame Anna Dominiczak

  

Vice President

2026 – 2028

Anna Dominiczak is the Regius Chair of Medicine at the University of Glasgow, Honorary Consultant Physician and Endocrinologist at NHS Greater Glasgow and Clyde, and Chief Scientist (Health) for the Scottish Government.

Anna was appointed to her role as Chief Scientist (Health) in July 2022, where she leads Scotland's health research and innovation agenda, working in partnership with the Scottish NHS, academia and industry in a triple helix partnership to accelerate the translation and adoption of research and innovation for the benefit of patients.

Recognised internationally as a world leader in cardiovascular science, clinical academia and precision medicine, her research focuses on hypertension, cardiovascular genomics and precision medicine. She has published more than 550 peer-reviewed papers in top journals (with an h-index of 129), secured over £100 million in research funding, delivered more than 100 international plenary lectures, and made a significant contribution to advancing cardiovascular medicine and Scotland's global reputation for health research and innovation.

Anna held the British Heart Foundation Chair of Cardiovascular Medicine at the University of Glasgow from 1997 to 2010 and served as the Director of the BHF Cardiovascular Research Centre between 2000 and 2010. From 2010 to 2020, she served as Vice-Principal and Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow, where she led the development of the University's clinical academic campus at the Queen Elizabeth University Hospital and championed a successful partnership between academia, the NHS and industry to accelerate innovation, improve patient outcomes and drive economic growth.

She is a Fellow of the Academy of Medical Sciences, the Royal Society of Edinburgh, the American Heart Association and the Royal College of Physicians. She has held numerous international leadership positions, including President of the European Society of Hypertension and President of the Association of Physicians of Great Britain and Ireland. She was appointed Dame Commander of the Order of the British Empire (DBE) in 2016 for services to cardiovascular and medical science.

 

 

Dr Philip Lewis

Secretary

2026 - 2028

Philip Lewis is the Senior Cardiologist at the Alexandra Hospital and at Stockport NHS Foundation Trust and an expert in preventive cardiology and therapeutics including cholesterol and weight management and was the lead cardiologist supervising the Stockport Cardiovascular Prevention Screening Project in which over 200,000 residents had screening for heart disease risk factors, and which informed the current NHS Health Checks Service.

He is the most clinically experienced blood pressure specialist in the North West, actively involved in university research on measurement of blood pressure, teaching and advising on matters of hypertension at a national level. He has been described as a “Super Forecaster” who is able to use advanced therapeutic approaches to treat cardiovascular disease using approaches before they have reached the level of routine use. and to cope with complex cases where several other health conditions coexist.

 

 

Dr Luca Faconti

Treasurer

2023 - 2027

Luca Faconti is a Clinical Lecturer in the Department of Clinical Pharmacology at King's College London and Honorary Consultant at Guy's and St Thomas' NHS Foundation Trust. Luca completed his medical training in Pisa (ESH Excellence Centre) and started his involvement in the BIHS as the Young Investigator Representative (2019 to 2022)

 

 

Dr Helen Warren

Ordinary Member

2024 - 2027

Helen is a Senior Lecturer at the William Harvey Research Institute, Queen Mary University of London (since 2013), working in the field of cardiovascular genetics. Her research focuses on the genetic discovery for blood pressure, risk prediction for hypertension, and pharmacogenetics for the response to both antihypertensive drugs and statins. She is the lead genetic analyst for ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) and BRIGHT (British Genetics of Hypertension study). Helen is a senior leader of the International Consortium of Blood Pressure, the Genomic Investigation of Statin Therapy Consortium, and International Consortium for Antihypertensive Pharmacogenetics Studies.

She has been a BIHS member since 2014, a Trustee & Executive Committee member since 2024, and a Collaborative Research Committee member since 2017.

 

 

Dr Manish Saxena

Ordinary Member

2024 - 2027

Manish Saxena, is a Cardiovascular Physician and Hypertension Specialist at Barts Health NHS Trust and Queen Mary University London. His research interest is in developing novel therapies to improve patient outcomes and prevention of cardiovascular/metabolic diseases. He is UK lead on academic and commercial studies with pharmaco-therapy and devices in dyslipidaemia, obesity, hypertension, heart failure, diabetes, inflammation and anti-coagulation.

Manish works closely with Health Research Authority as an expert member and  National Research Ethics Committee Chair. He is Deputy Director for research at Barts Health NHS Trust and QMUL. He has been recognised as leading Principal investigator by NIHR.

 

 

 

Dr Ryan McNally

Ordinary Member

2024 - 2027

Ryan McNally is a postdoctoral Research Associate in the Department of Vascular Risk and Surgery, School of Cardiovascular Medicine and Sciences, Faculty of Life Sciences and Medicine. Ryan's postdoctoral research project was a joint clinical study between King’s College London and the University of Cambridge investigating salt-sensitivity in the pathogenesis of hypertension. He is now conducting research into personalised medicine for hypertension at the King's Health Partners Centre for Translational Medicine and is working as a pharmacist at St. Thomas' Hospital. Ryan is also member of the European Society of Hypertension Young Investigator Committee.

 

 

Professor Christopher Clark

Ordinary Member

2026 - 2028

Chris studied Medicine and Physiology at University of Bristol Medical School, graduating in 1986. He joined the Mid Devon Medical Practice in 1994 as a partner, then Senior Partner, and continued working there until December 2020. He joined the Medical School as a Clinical Academic Fellow in 2004, completed his MSc in 2006 and his PhD in 2013. He was appointed NIHR Clinical Lecturer in 2014, Clinical Senior Lecturer in 2015, and is now Clinical Associate Professor of Primary Care Cardiovascular Medicine.

He has broad ranging primary care research interests, but focusses on cardiovascular themes including: Significance and implications of a difference in blood pressures between arms; Organisation and management of care in hypertension in primary care; Estimation and early detection of cardiovascular risk; Recognition and management of postural hypotension in primary care.

 

 

 

Dr Tehreem Butt

Ordinary Member

2026 - 2028

Tehreem Butt is a Consultant in Acute Medicine and Clinical Pharmacology/Hypertension at Mid and South Essex Hospitals NHS Trust, Honorary Senior Lecturer at Anglia Ruskin University Medical School, and Chair of the trust’s Medicines Safety Group.

She set up the first commissioned  Specialist Hypertension service in Essex and currently leads on hypertension-related research in the region as well as conducting the national May Measurement Month campaign. As an acute physician, she is committed to improving the management of hypertensive crises, and passionate about developing outpatient hypertension services in areas where they are lacking. She is heavily involved in both undergraduate and postgraduate medical education, and has been a member of the BIHS Education Standing committee since 2022, helping deliver educational programmes and digital resources to both healthcare professionals and patients.